Vantage Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$7.08M Buy
34,897
+2,437
+8% +$480K 1.49% 26
2018
Q2
$5.99M Buy
32,460
+1,102
+4% +$195K 1.46% 26
2018
Q1
$5.35M Sell
31,358
-587
-2% -$108K 1.36% 31
2017
Q4
$5.55M Buy
31,945
+1,139
+4% +$202K 1.28% 27
2017
Q3
$5.74M Buy
30,806
+1,907
+7% +$338K 1.48% 21
2017
Q2
$4.98M Buy
28,899
+9,795
+51% +$1.59M 1.44% 28
2017
Q1
$3.13M Buy
19,104
+2,759
+17% +$458K 1.03% 36
2016
Q4
$2.39M Buy
16,345
+904
+6% +$136K 0.97% 38
2016
Q3
$2.58M Sell
15,441
-1,692
-10% -$286K 1.15% 33
2016
Q2
$2.6M Buy
17,133
+318
+2% +$49.4K 1.1% 28
2016
Q1
$2.51M Buy
16,815
+2,739
+19% +$407K 1.11% 28
2015
Q4
$2.29M Buy
14,076
+1,775
+14% +$279K 1.15% 27
2015
Q3
$1.7M Buy
12,301
+590
+5% +$93K 0.96% 31
2015
Q2
$1.8M Sell
11,711
-9,813
-46% -$1.57M 0.99% 29
2015
Q1
$3.44M Buy
21,524
+10,473
+95% +$1.65M 0.98% 31
2014
Q4
$1.76M Buy
11,051
+369
+3% +$57.5K 0.99% 31
2014
Q3
$1.5M Buy
10,682
+236
+2% +$30.8K 0.91% 33
2014
Q2
$1.24M Buy
10,446
+460
+5% +$53.2K 0.76% 37
2014
Q1
$1.23M Buy
9,986
+8,425
+540% +$1.02M 0.81% 39
2013
Q4
$178K Buy
+1,561
New +$178K 0.12% 108

Other funds holding AMGN

Vantage Investment Advisors's AMGN Position: Q3 2018 in Review

Vantage Investment Advisors increased its Amgen (AMGN) stake by 7.5% in Q3 2018, buying an estimated $480K and bringing the position to 34,897 shares worth $7.08M. The position accounts for 1.49% of the portfolio, ranked #26.

Vantage Investment Advisors first reported a position in AMGN in Q4 2013 and has held it in 20 quarters since. 1,796 funds tracked by Wall St. Rank hold AMGN as of Q3 2018.

  • Vantage Investment Advisors held 34,897 shares of Amgen worth $7.08M as of Q3 2018.
  • Vantage Investment Advisors bought 2,437 Amgen shares in Q3 2018, an estimated $480K.
  • Amgen made up 1.49% of Vantage Investment Advisors's portfolio in Q3 2018, its #26 holding.
  • Vantage Investment Advisors first reported a position in Amgen in Q4 2013 and has held it in 20 quarters since.
  • 1,796 funds tracked by Wall St. Rank held Amgen as of Q3 2018.

Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.